241 related articles for article (PubMed ID: 26601811)
1. Evolving management of low grade glioma: No consensus amongst treating clinicians.
Field KM; Rosenthal MA; Khasraw M; Sawkins K; Nowak AK
J Clin Neurosci; 2016 Jan; 23():81-87. PubMed ID: 26601811
[TBL] [Abstract][Full Text] [Related]
2. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
McDuff SGR; Dietrich J; Atkins KM; Oh KS; Loeffler JS; Shih HA
Cancer Med; 2020 Jan; 9(1):3-11. PubMed ID: 31701682
[TBL] [Abstract][Full Text] [Related]
3. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.
Neyns B; Sadones J; Chaskis C; De Ridder M; Keyaerts M; Veld PI; Michotte A
Acta Neurol Belg; 2005 Sep; 105(3):137-43. PubMed ID: 16255151
[TBL] [Abstract][Full Text] [Related]
4. Low-grade gliomas.
Ruiz J; Lesser GJ
Curr Treat Options Oncol; 2009 Aug; 10(3-4):231-42. PubMed ID: 19381819
[TBL] [Abstract][Full Text] [Related]
5. Current management of low-grade gliomas.
Hottinger AF; Hegi ME; Baumert BG
Curr Opin Neurol; 2016 Dec; 29(6):782-788. PubMed ID: 27676279
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary management of adult low grade gliomas.
Mariş D; Nica D; Mohan D; Moisa H; Ciurea AV
Chirurgia (Bucur); 2014; 109(5):590-9. PubMed ID: 25375042
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T; Lim DH; Seol HJ; Park CK; Kim IH; Chang JH; Lee J; Jung S; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
J Neurooncol; 2018 Jul; 138(3):667-677. PubMed ID: 29572674
[TBL] [Abstract][Full Text] [Related]
8. Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?
Laack NN; Sarkaria JN; Buckner JC
Semin Radiat Oncol; 2015 Jul; 25(3):197-202. PubMed ID: 26050590
[TBL] [Abstract][Full Text] [Related]
9. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
10. Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review.
Hafazalla K; Sahgal A; Jaja B; Perry JR; Das S
Oncotarget; 2018 Sep; 9(72):33623-33633. PubMed ID: 30263090
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic glioma: current treatment and management.
Le Rhun E; Taillibert S; Chamberlain MC
Expert Rev Neurother; 2015 Jun; 15(6):601-20. PubMed ID: 25936680
[TBL] [Abstract][Full Text] [Related]
12. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
13. Low-grade and anaplastic oligodendroglioma.
Van Den Bent MJ; Bromberg JE; Buckner J
Handb Clin Neurol; 2016; 134():361-80. PubMed ID: 26948366
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic decision making in patients with newly diagnosed low grade glioma.
Tandon A; Schiff D
Curr Treat Options Oncol; 2014 Dec; 15(4):529-38. PubMed ID: 25139406
[TBL] [Abstract][Full Text] [Related]
15. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
Etxaniz O; Carrato C; de Aguirre I; Queralt C; Muñoz A; Ramirez JL; Rosell R; Villà S; Diaz R; Estival A; Teixidor P; Indacochea A; Ahjal S; Vilà L; Balañá C
J Neurooncol; 2017 Nov; 135(2):273-284. PubMed ID: 28884377
[TBL] [Abstract][Full Text] [Related]
16. Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersociety (SINch/AINO/SIN) document.
Rudà R; Angileri FF; Ius T; Silvani A; Sarubbo S; Solari A; Castellano A; Falini A; Pollo B; Del Basso De Caro M; Papagno C; Minniti G; De Paula U; Navarria P; Nicolato A; Salmaggi A; Pace A; Fabi A; Caffo M; Lombardi G; Carapella CM; Spena G; Iacoangeli M; Fontanella M; Germanò AF; Olivi A; Bello L; Esposito V; Skrap M; Soffietti R;
J Neurosurg Sci; 2020 Aug; 64(4):313-334. PubMed ID: 32347684
[TBL] [Abstract][Full Text] [Related]
17. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
[TBL] [Abstract][Full Text] [Related]
18. [Controversy in the Postoperative Treatment of Low-grade Gliomas].
Kazda T; Lakomý R; Poprach A; Pospíšil P; Jančálek R; Šlampa P
Klin Onkol; 2017; 30(5):337-342. PubMed ID: 29031035
[TBL] [Abstract][Full Text] [Related]
19. Management of low-grade glioma.
Pouratian N; Schiff D
Curr Neurol Neurosci Rep; 2010 May; 10(3):224-31. PubMed ID: 20425038
[TBL] [Abstract][Full Text] [Related]
20. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
